SEBELA PHARMACEUTICALS RXDIRECT

Serial Number 88052552
Registration 5985373
700

Registration Progress

Application Filed
Jul 25, 2018
Under Examination
Apr 2, 2019
Approved for Publication
Feb 5, 2019
Published for Opposition
Feb 5, 2019
Registered
Feb 11, 2020

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20200211)
Due: Feb 11, 2026 46 days

Trademark Image

SEBELA PHARMACEUTICALS RXDIRECT

Basic Information

Serial Number
88052552
Registration Number
5985373
Filing Date
July 25, 2018
Registration Date
February 11, 2020
Published for Opposition
February 5, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 11, 2020
Registration
Registered
Classes
035

Rights Holder

SEBELA IRELAND LIMITED

11
Address
3RD FLOOR, WEST WING, ADELAIDE CHAMBERS,
PETER STREET
DUBLIN 8
IE

Ownership History

SEBELA INTERNATIONAL BERMUDA LIMITED

Original Applicant
11
Hamilton BM

SEBELA INTERNATIONAL BERMUDA LIMITED

Owner at Publication
11
Hamilton BM

SEBELA IRELAND LIMITED

New Owner After Publication #1
11
DUBLIN IE

SEBELA IRELAND LIMITED

Original Registrant
11
DUBLIN IE

Legal Representation

Attorney
Jeffrey H. Handelsman

USPTO Deadlines

Next Deadline
46 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20200211)
Due Date
February 11, 2026
Grace Period Ends
August 11, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

29 events
Date Code Type Description Documents
Feb 11, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Feb 11, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 10, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jan 9, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 4, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 2, 2019 IUAF S USE AMENDMENT FILED Loading...
Oct 8, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 7, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 2, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 7, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 2, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 2, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jul 24, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Apr 2, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 5, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 5, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 16, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 31, 2018 ALIE A ASSIGNED TO LIE Loading...
Dec 11, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 28, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 28, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 28, 2018 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Nov 28, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 18, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 18, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 18, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 13, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 30, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 28, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Mail order pharmacy services; Mail order services featuring prescription drug products or services and medical supplies; Order fulfillment of pharmaceuticals; Order fulfillment services, namely, monitoring and tracking the order status of prescription drugs, drug therapy, prescription refills; Order fulfillment and home delivery services featuring prescription drug products or services and medical supplies; Business administration of patient reimbursement programs
First Use Anywhere: Feb 2, 2018
First Use in Commerce: Feb 2, 2018

Additional Information

Pseudo Mark
SEBELA PHARMACEUTICALS RX DIRECT

Classification

International Classes
035

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS RXDIRECT"